Modifying quinolone antibiotics yields new anxiolytics

@article{Johnstone2004ModifyingQA,
  title={Modifying quinolone antibiotics yields new anxiolytics},
  author={Timothy B C Johnstone and Derk J. Hogenkamp and Leanne Coyne and Jiping Su and Robert F. Halliwell and Minhtam B. Tran and Ryan F. Yoshimura and Wen-Yen Li and Jeff J.-H. Wang and Kelvin W. Gee},
  journal={Nature Medicine},
  year={2004},
  volume={10},
  pages={31-32}
}
Patients taking fluoroquinolone antibiotics such as norfloxacin exhibit a low incidence of convulsions and anxiety. These side effects probably result from antagonism of the neurotransmitter γ-aminobutyric acid (GABA) at the brain GABAA receptor complex (GRC). Modification of norfloxacin yields molecules such as compound 4 that potentiate GABA action with α2 subunit selectivity. Compound 4 is anxiolytic but does not cause sedation, and may represent a new class of ligands that have anxiolytic… 
View on Springer
ncbi.nlm.nih.gov
45 Citations
Highly Influential Citations
1
Background Citations
15
Methods Citations
1

45 Citations

Citation Type

Citation Type

Anxioselective anxiolytics: can less be more?
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
  • A. Lippa, P. Czobor, P. Skolnick
  • Psychology, Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2005
TLDR
It is reported that the pyrazolo[1,5-a]-pyrimidine, ocinaplon, exhibits an anxioselective profile in both preclinical procedures and in patients with generalized anxiety disorder, the most common of the anxiety disorders.
Anxiogenic potential of prulifloxacin in experimental animal model
TLDR
The result suggested that prulifloxacin exerted anxiety-like effect in the elevated plus maze, hole board apparatus and light/dark exploration test in mice.
The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics
  • J. Atack
  • Biology, Psychology
    Expert opinion on investigational drugs
  • 2005
TLDR
The advent of molecular genetic and pharmacological approaches has begun to delineate which GABAA receptor subtypes are associated with the various pharmacological effects of the non-selective BZs, raising the possibility of a compound that selectively modulates α2- and/or α3- containing receptors but does not affect α1-containing receptors would be a non-sedating anxiolytic.
GABA-A receptors: a viable target for novel anxiolytics?
  • P. Whiting
  • Biology, Psychology
    Current opinion in pharmacology
  • 2006
GABAA receptor subtype selectivity underlying selective anxiolytic effect of baicalin
GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone.
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA α2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers
TLDR
Although less effect on VAs alertness was expected, diminished effects on memory and postural stability were present and clinical studies in anxiety patients should show whether this dose of MK-0343 is therapeutically effective with a different side-effect profile.
Chapter 4.2 Subtype-selective GABAA/benzodiazepine receptor ligands for the treatment of anxiety disorders
Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator
TLDR
Results suggest that β2/3-subunit subtype-selective GABAA receptor-positive allosteric modulators not only have reduced sedative liability, but also a reduction in other central side effects commonly associated with broader GabAA receptor activation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
TLDR
This work created genetically modified mice with a diazepam-insensitive α1 subtype and a selective BZ site ligand to explore GABAA receptor subtypes mediating specific physiological effects and revealed that the α1Subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines.
Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety
TLDR
The results raise the possibility that in addition to 3 α,5α-P and 3α,5β-P, some of their endogenously occurring pregnanediol metabolites may also influence physiological processes related to anxiety via the GRC.
Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Effects of Novel 6-Desfluoroquinolones and Classic Quinolones on Pentylenetetrazole-Induced Seizures in Mice
TLDR
The relationship between the chemical structure and the proconvulsant activity of 6-desfluoroquinolone derivatives was studied and it was observed that, in terms of toxicity to the central nervous system (CNS), the C-6 substituent also appears to play an important role.
Drug interactions at GABAA receptors
A simple and reliable conflict procedure for testing anti-anxiety agents
TLDR
The results indicated that this simple procedure clearly demonstrated “anti-anxiety” (i.e., increases in punished responding) effects with benzodiazepines, meprobamate and pentobarbital.
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Nature as medicine.
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.
Antagonism of GABAA receptors by 4-quinolones.
...
1
2
...